Latest Materials News

Smartgroup Corporation Ltd reported a solid first half for 2025 with revenue up 7% and net profit rising 11%, powered by strong novated leasing growth amid shifting electric vehicle policies.

Mineral Resources Limited reported a challenging FY25 with a 15% drop in revenue and underlying EBITDA amid weaker commodity prices, while Onslow Iron reached its nameplate capacity, setting the stage for FY26 growth.

Sprintex Limited reported a 26% revenue increase for FY25 but also a 37% rise in net loss, as it accelerates global expansion through key distribution deals and manufacturing upgrades.

Estrella Resources has launched a comprehensive drone and geophysical survey program across its manganese and limestone projects in Timor-Leste, aiming to sharpen geological models and enhance drill targeting ahead of upcoming campaigns.

Coda Minerals reports a metallurgical breakthrough at its Elizabeth Creek project, significantly increasing copper and silver recoveries while reducing costs, leading to a substantial uplift in project economics. The simplified flowsheet excludes cobalt from the base case, lowering risk and positioning cobalt as future upside.

Alcidion Group Limited has reported a transformative FY25 with record earnings, a major NHS contract win, and a robust outlook for FY26. The company’s healthcare technology platform is gaining traction across the UK and Australia, setting the stage for accelerated growth.

Air New Zealand reported a resilient $126 million net profit for FY2025 despite grounding up to 11 aircraft due to engine maintenance issues, while advancing its net zero emissions commitment with a new 2030 guidance.

IGO Limited reported a significant net loss for FY25 driven by a $605 million impairment at its Kwinana lithium refinery and challenging market conditions. Despite setbacks, the Greenbushes operation maintained strong margins, and the company is advancing a refreshed strategy focused on clean energy materials.

Centuria Industrial REIT (ASX – CIP) has announced a $300 million exchangeable notes offering due 2030, alongside a concurrent repurchase of existing notes, aiming to lower debt costs and extend maturity. The move underscores CIP’s strategic capital management amid a complex market environment.

Biotron Limited reported a significantly reduced net loss of $318,572 for FY2025, bolstered by a $1.27 million capital raise and a $1.81 million R&D tax rebate, as it advances clinical and preclinical antiviral programs.

Shriro Holdings reported a 5.5% rise in EBITDA for FY25 despite a 13.6% revenue dip, driven by strategic shifts including a new US distributor and innovative BBQ product launches.

Imagion Biosystems reported a $1.66 million loss for the half-year ending June 2025 while progressing its MagSense® HER2 Imaging Agent towards a Phase 2 FDA trial and securing $3.5 million in new funding.